English

Daraxonrasib

Daraxonrasib Featured Image
  • Daraxonrasib

Short Description:

API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status 
Daraxonrasib 2765081-21-6  2027   Jan.24, 2042 estimated PV Completion – Mar, 2028

 

[Indication] 

  • For the treatment of patients with previously treated metastatic pancreatic ductal adenocarcinoma (PDAC).


Product Detail

Product Tags

  • Previous:
  • Next:
    • Write your message here and send it to us

    Products categories